Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Simple Search

Search Type: Criteria:

You could also try: included (1000), integrated (151)

Papers-CoG 26.04.2023

Description: Agenda attachments 1 CoG Agenda - 26.04.2023.docx Date Time Location Chair Agenda Council of Governors 26/04/2023 14
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Governors/Papers-CoG-26.04.2023.pdf

Gemcitabine-Paclitaxel Albumin Bound (Abraxane)

Description: Chemotherapy Protocol PANCREATIC CANCER GEMCITABINE-PACLITAXEL ALBUMIN BOUND Regimen • Pancreatic Cancer – Gemcitabine-Paclitaxel Albumin Bound Indication • First line treatment of adult
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Pancreas/Gemcitabine-Paclitaxel-Albumin-Bound-Abraxane-Ver2.pdf

Papers Trust Board - 30 January 2024

Description: Date Time Location Chair Apologies Agenda Trust Board – Open Session 30/01/2024 9:00 - 13:00 Conference Room, Heartbeat/Microsoft
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2024-Trust-documents/Papers-Trust-Board-30-January-2024.pdf

InP-Cisplatin-Etoposide-Ifosfamide (VIP)

Description: Chemotherapy Protocol GERM CELL CISPLATIN-ETOPOSIDE-IFOSFAMIDE (VIP) Inpatient Regimen Regimen • Germ Cell – InP-Cisplatin-Etoposi
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Germcell/InP-Cisplatin-Etoposide-Ifosfamide-VIP.pdf

Quality Committee ToR December 2021

Description: Terms of Reference for a Quality Committee in December 2021.
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2022-Trust-documents/Quality-Committee-ToR-December-2021.pdf

Cisplatin, Vinorelbine and radiotherapy

Description: Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) CISPLATIN - VINORELBINE (RADIOTHERAPY) Regimen NSCLC – Cisplatin - Vinorelbine (Radiotherapy) Indication First line the
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/CisplatinVinorelbineandradiotherapyver12.pdf

Cisplatin and Vinorelbine (intravenous-adjuvant)

Description: Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) CISPLATIN-VINORELBINE (Intravenous - Adjuvant) Regimen NSCLC – Cisplatin-Vinorelbine (Intravenous-Adjuvant) Indication
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/CisplatinandVinorelbineintravenous-adjuvantver12.pdf

Cisplatin and Vinorelbine (intravenous)

Description: Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) CISPLATIN-VINORELBINE (Intravenous) Regimen NSCLC – Cisplatin-Vinorelbine IV Indication First line therapy of stage III
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/CisplatinandVinorelbineintravenousver12.pdf

Cisplatin and Pemetrexed

Description: Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) CISPLATIN-PEMETREXED Regimen NSCLC – Cisplatin-Pemetrexed Indication First line therapy of stage III or IV adenocarcinoma or la
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/CisplatinandPemetrexedver12.pdf

Cisplatin and Gemcitabine

Description: Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) CISPLATIN-GEMCITABINE Regimen NSCLC – Cisplatin-Gemcitabine Indication Non-small cell
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/CisplatinandGemcitabinever12.pdf

61 to 70 of 115

Previous … 5 6 7 8 9 … Next